Live Breaking News & Updates on Analyst Recommendations For Exact Sciences

Stay updated with breaking news from Analyst recommendations for exact sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Exact Sciences (NASDAQ:EXAS) Upgraded at Craig Hallum

Craig Hallum upgraded shares of Exact Sciences (NASDAQ:EXAS – Get Rating) from a hold rating to a buy rating in a research note issued to investors on Wednesday morning, The Fly reports. They currently have $85.00 target price on the medical research company’s stock, up from their prior target price of $55.00. Other analysts have […] ....

Craig Hallum , Jeffrey Thomas Elliott , Robertw Baird , Sarah Condella , Benjamin Edwards Inc , Sciences Corp , Securities Exchange Commission , Desjardins Global Asset Management Inc , Credit Suisse Group , Sciences Stock Performance , Institutional Investors Weigh In On Exact Sciences , Managers Group , Analyst Recommendations For Exact Sciences , Wealth Partners , News Ratings For Exact Sciences Daily , Exact Sciences , Get Rating , Suisse Group , Moderate Buy , Exchange Commission , Thomas Elliott , Global Asset Management , Exact Sciences Daily , Nasdaq Exas ,

Exact Sciences (NASDAQ:EXAS) PT Raised to $88.00

Exact Sciences (NASDAQ:EXAS – Get Rating) had its price objective increased by Bank of America from $80.00 to $88.00 in a research note published on Wednesday, The Fly reports. EXAS has been the subject of several other reports. Raymond James downgraded shares of Exact Sciences from an outperform rating to a market perform rating in […] ....

United States , Jeffrey Thomas Elliott , Raymond James , Sarah Condella , Sciences Corp , Oppenheimer Co , Sciences Company Profile , Analyst Recommendations For Exact Sciences , Sciences Stock Performance , Advisor Group , News Ratings For Exact Sciences Daily , Atria Investments Inc , Insider Transactions At Exact Sciences , Register Financial Advisors , Sohn Co , Exact Sciences , Get Rating , Moderate Buy , Thomas Elliott , Investments Inc , Financial Advisors , Exact Sciences Daily , Nasdaq Exas , Boost Price Target , Bank Of America Co ,

Exact Sciences (NASDAQ:EXAS) Price Target Raised to $100.00

Exact Sciences (NASDAQ:EXAS – Get Rating) had its target price hoisted by equities research analysts at Citigroup from $90.00 to $100.00 in a report issued on Thursday, The Fly reports. Citigroup’s target price would suggest a potential upside of 27.02% from the company’s previous close. Several other brokerages have also weighed in on EXAS. StockNews.com […] ....

Stifel Nicolaus , Kevint Conroy , Benjamin Edwards Inc , Sciences Company Profile , Sciences Stock , Desjardins Global Asset Management Inc , Managers Group , Sciences Corp , Securities Exchange Commission , Wealth Partners , News Ratings For Exact Sciences Daily , Analyst Recommendations For Exact Sciences , Credit Suisse Group , Exact Sciences , Get Rating , Suisse Group , Directord Scott Coward , Exchange Commission , Global Asset Management , Exact Sciences Daily , Nasdaq Exas , Boost Price Target , Citigroup Inc ,

Exact Sciences (NASDAQ:EXAS) Given New $85.00 Price Target at Stifel Nicolaus

Exact Sciences (NASDAQ:EXAS – Get Rating) had its price target increased by Stifel Nicolaus from $75.00 to $85.00 in a research note published on Wednesday, The Fly reports. Several other brokerages also recently weighed in on EXAS. Piper Sandler increased their price target on Exact Sciences from $50.00 to $70.00 and gave the stock a […] ....

Piper Sandler , Stifel Nicolaus , Sarah Condella , Jacoba Orville , News Ratings For Exact Sciences Daily , Canaccord Genuity Group , Sciences Stock , Institutional Investors Weigh In On Exact Sciences , Assetmark Inc , Sciences Company Profile , Sciences Corp , True Wealth Design , Park Place Capital Corp , Desjardins Global Asset Management Inc , Analyst Recommendations For Exact Sciences , Exact Sciences , Get Rating , Genuity Group , Moderate Buy , Place Capital Corp , Global Asset Management , Wealth Design , Exact Sciences Daily , Nasdaq Exas , Boost Price Target ,

Exact Sciences (NASDAQ:EXAS) Upgraded to "Buy" at Craig Hallum

Craig Hallum upgraded shares of Exact Sciences (NASDAQ:EXAS – Get Rating) from a hold rating to a buy rating in a research report released on Wednesday morning, The Fly reports. The firm currently has $85.00 price objective on the medical research company’s stock, up from their previous price objective of $55.00. Other equities research analysts […] ....

Sarah Condella , Craig Hallum , News Ratings For Exact Sciences Daily , Sciences Price Performance , True Wealth Design , Canaccord Genuity Group , Sciences Corp , Assetmark Inc , Institutional Investors Weigh In On Exact Sciences , Analyst Recommendations For Exact Sciences , Desjardins Global Asset Management Inc , Park Place Capital Corp , Exact Sciences , Get Rating , Genuity Group , Moderate Buy , Directord Scott Coward , Place Capital Corp , Global Asset Management , Wealth Design , Exact Sciences Daily , Nasdaq Exas ,